Medisoft Pharma
Glimepiride (2mg) + Metformin (500mg)
Metjet-MG2 Tablet SR is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet SR
Metjet-MG2 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Metjet-MG2 Tablet SR is to be taken with food.
It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
It is unsafe to consume alcohol with Metjet-MG2 Tablet SR.
Metjet-MG2 Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Metjet-MG2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Metjet-MG2 Tablet SR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
You should continue to exercise regularly Eat a healthy diet Take your other diabetes medicines along with Metjet-MG2 Tablet SR. Take it with food to lower your chance of having an upset stomach. Monitor your blood sugar level regularly while you are taking this medicine.
Store this medicine in its original container or package, tightly closed. Refer to the instructions provided on the package label for specific storage guidance. Dispose of unused medication properly. Ensure that it is inaccessible to pets, children, and other individuals.
Yes, using Metjet-MG2 Tablet SR can contribute to lactic acidosis. This is a medical emergency triggered by elevated levels of lactic acid in the bloodstream, also known as MALA (Metformin-associated lactic acidosis). It is a rare side effect associated with metformin and therefore poses a risk for patients with underlying kidney disease, those aged 65 or older, and individuals who consume significant amounts of alcohol. If experiencing symptoms like muscle pain or weakness, dizziness, fatigue, feelings of coldness in arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or slow heart rate, discontinue Metjet-MG2 Tablet SR immediately and seek medical attention promptly.
Metjet-MG2 Tablet SR is a combination of two drugs: Glimepiride and Metformin. This medication is prescribed to manage type 2 diabetes mellitus (DM). It enhances blood glucose levels in adults when combined with proper diet and regular exercise. Glimepiride decreases blood glucose by promoting insulin release from the pancreas. Metformin reduces glucose production in the liver and improves insulin sensitivity. It should not be used for treating type 1 DM.
Common side effects associated with using Metjet-MG2 Tablet SR include hypoglycemia (low blood sugar level), changes in taste, nausea, stomach pain, diarrhea, and headache. In the long term, it can lead to Vitamin B12 deficiency. Severe but rare side effects may occur, including lactic acidosis.
Yes, prolonged use of Metjet-MG2 Tablet SR can lead to a lack of vitamin B12. This is caused by its interference with the absorption of vitamin B12 in the stomach. Untreated, this deficiency can result in anemia and nerve problems such as tingling sensations in the hands and feet, weakness, urinary difficulties, changes in mental status, and difficulty maintaining balance (ataxia). To mitigate these risks, experts recommend regular intake of vitamin B12 from external sources at least once annually.
Yes, the use of Metjet-MG2 Tablet SR can induce hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and feelings of anxiety or shakiness. It is more likely to occur when missing meals, consuming alcohol, overexercising, or taking other antidiabetic medications simultaneously. Regular blood sugar monitoring is essential to ensure accurate control.
No, consuming alcohol along with Metjet-MG2 Tablet SR is not advisable. Alcohol use can further lower blood sugar levels and contribute to hypoglycemia. This increases the risk of lactic acidosis.